Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Steward Health Ch. 11 Lifts Lid On PE In Healthcare No Photo Available

Clara Geoghegan

Steward Health's $9 billion Chapter 11 has come under scrutiny from state attorneys general seeking to uncover why a once-rapidly grow... (more story)

Many Plans Already In Front Of 11th Circ. Trans Health Ruling No Photo Available

Kellie Mejdrich

The Eleventh Circuit's recent decision that a county health plan's coverage exclusion for gender transition surgery violated federal a... (more story)

Healthcare Deals This Week: AbbVie, Takeda And More No Photo Available

Yeji Jesse Lee

From a research collaboration focused on obesity management to blockbuster collaboration deals that included names like AbbVie, Takeda... (more story)